Treatment of patients with diabetes and periodontal disease with topical melatonin was associated with a significant improvement in the gingival index and in pocket depth, and a statistically significant reduction in concentrations of IL-1β, IL-6 and PGE2 in gingival crevicular fluid. Here, IL1B is linked to periodontal disorder.